№ lp_2_1_01074
File format: docx
Character count: 6397
File size: 30 KB
Regulatory guidance text defining the structure, content, and scientific considerations required for the Nonclinical Overview section of a Common Technical Document submitted for pharmaceutical registration.
Document Type:
Regulatory guidance
Module:
2.4 Nonclinical Overview
Framework:
Common Technical Document (CTD)
Related Guideline:
M4 Organization of the Common Technical Document for the Registration of Pharmaceuticals for Human Use
Note:
Related Guideline
Guidance for Industry M4S: The CTD — Safety
Subject:
Nonclinical testing strategy, pharmacology, pharmacokinetics, and toxicology
Intended Application:
Registration of pharmaceuticals for human use
Referenced Standards:
Good Laboratory Practice (GLP)
Scope:
Evaluation of pharmacologic, pharmacokinetic, toxicologic, and impurity data
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
International
Theme:
Research Ethics
Document Type:
Standard Operating Procedure (SOP)
Organ / Institution:
ISU-IREB
Author:
ISU-IREB SOP Team
Target Audience:
Researchers, IREB Members
Period of Validity:
Ongoing
Approval Date:
2026-02-03
Date of Changes:
N/A
Year:
2021
Region / city:
N/A
Subject area:
Toxicology
Document type:
Template
Author:
BioCelerate
Target audience:
Researchers, regulatory professionals
Period of validity:
N/A
Approval date:
N/A
Amendment date:
N/A
Year:
2026
Region / city:
N/A
Subject:
Pharmaceutical regulatory submission
Document type:
Submission guidelines
Authority / institution:
N/A
Author:
N/A
Target audience:
Applicants for pharmaceutical submissions
Validity period:
N/A
Approval date:
N/A
Amendment date:
N/A
Note:
Year
Contextual description:
A checklist for the submission of variations related to type II clinical and non-clinical changes to product information in the European market.
Year:
N/A
Region / City:
N/A
Subject:
Toxicology Study Plan/Protocol
Document Type:
Template
Organization / Institution:
BioCelerate
Author:
N/A
Target Audience:
Researchers, Sponsors, and CROs involved in nonclinical studies
Period of Validity:
N/A
Approval Date:
N/A
Modification Date:
N/A
Note:
Year
Topic:
Wastewater Regulation
Document Type:
Form
Year:
2026
Region / City:
Global
Topic:
Regulatory Compliance, Certification
Document Type:
Notification Form
Organization / Institution:
SGS
Author:
SGS
Target Audience:
Clients holding SGS certification
Period of Validity:
Ongoing
Approval Date:
N/A
Date of Changes:
N/A
Contextual Description:
A form for notifying SGS of any changes or regulatory actions affecting the validity or scope of certification for medical devices.
Year:
2021
Region / City:
West and Central Africa
Topic:
Electricity, Governance, Institutional Strengthening, Africa
Document Type:
Report
Organization:
European Union, African Union Commission
Author:
Dr. Dimitris Papastefanakis, Dr. William Gboney, Dr. George Kyriakarakos, Mr. Jian Bani
Target Audience:
Policy makers, energy sector professionals
Period of Validity:
2021-2040
Approval Date:
August 31, 2021
Date of Revisions:
N/A
Note:
Year
Year:
2014
Region / City:
Global
Topic:
Pharmaceutical Product Prequalification
Document Type:
Guideline
Organization / Institution:
World Health Organization (WHO)
Author:
World Health Organization
Target Audience:
Pharmaceutical manufacturers, regulatory bodies
Effective Period:
Not specified
Approval Date:
2014
Modification Date:
Not specified
Note:
Year
Topic:
Pharmaceutical product, regulatory approval, prequalification
Document type:
Template
Organization / institution:
WHO
Target audience:
Regulatory authorities, pharmaceutical manufacturers
Year:
2023
Region / City:
United States
Subject:
Pharmaceutical Regulatory Guidance
Document Type:
Guidance
Organization / Institution:
FDA
Author:
FDA
Target Audience:
Industry stakeholders, Sponsors, Applicants
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Contextual Description
Year:
2023
Region / City:
Global
Topic:
Biopharmaceutical studies, bioavailability, bioequivalence
Document Type:
Regulatory Guidance
Agency / Institution:
FDA, EMA
Author:
Not specified
Target Audience:
Industry professionals in pharmaceuticals
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Year:
2026
Region / City:
Global
Topic:
Clinical Efficacy Studies
Document Type:
Guidance
Author:
FDA
Target Audience:
Industry professionals in pharmaceuticals
Action Period:
Ongoing
Approval Date:
N/A
Modification Date:
N/A
Description:
Regulatory guidance on the structure and numbering of templates in eCTD submissions, with a focus on the proper organization and presentation of efficacy studies in pharmaceutical documentation.
Year:
2023
Region / City:
Sellafield
Theme:
Nuclear Waste Management, Environmental Safety, Nuclear Regulatory Oversight
Document Type:
Regulatory Position Report
Organization / Institution:
Office for Nuclear Regulation (ONR)
Author:
Office for Nuclear Regulation (ONR)
Target Audience:
Stakeholders in nuclear safety, regulatory bodies, Sellafield Limited
Period of Validity:
Until MSSS waste retrieval completion (2045-2050)
Approval Date:
2023
Date of Amendments:
None
Year:
2021
Region / city:
Worldwide
Topic:
Biotherapeutic Product Documentation
Document type:
Guidelines
Organization / institution:
World Health Organization (WHO)
Author:
World Health Organization (WHO)
Target audience:
Regulatory authorities, pharmaceutical companies, healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2017
Region / city:
Wisconsin, Madison
Subject:
Radiation safety policy for dental facilities
Document type:
Regulatory guide
Institution / organization:
Department of Health Services, Division of Public Health, Radiation Protection Section
Author:
Wisconsin Department of Health Services
Target audience:
Dental facilities and operators
Period of validity:
Ongoing
Approval date:
April 2017
Date of changes:
N/A